相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's disease as oligomeropathy
Kenjiro Ono
NEUROCHEMISTRY INTERNATIONAL (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease
Gvido Cebers et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
BACE1 regulates the proliferation and cellular functions of Schwann cells
Xiangyou Hu et al.
GLIA (2017)
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A Peptides
Kei Sakamoto et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system
Lucas J. Sosa et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease
Xuan Ye et al.
JOURNAL OF NEUROSCIENCE (2017)
Stop Alzheimer's before it starts
Eric McDade et al.
NATURE (2017)
BACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and rats
Martin Weber et al.
SCIENTIFIC REPORTS (2017)
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
Riqiang Yan
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay
Malgorzata Rozga et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Decreased Plasma β-Amyloid in the Alzheimer's Disease APP A673T Variant Carriers
Henna Martiskainen et al.
ANNALS OF NEUROLOGY (2017)
Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1′-P2′ ligands
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
Mike Ufer et al.
Alzheimers & Dementia (2016)
Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions
Wei Hong Toh et al.
BIOCHEMICAL JOURNAL (2016)
New Directions for Protease Inhibitors Directed Drug Discovery
Yoshio Hamada et al.
BIOPOLYMERS (2016)
Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
Masuo Ohno
BRAIN RESEARCH BULLETIN (2016)
Post-translational regulation of the β-secretase BACE1
Wataru Araki
BRAIN RESEARCH BULLETIN (2016)
Ion channel regulation by -secretase BACE1-enzymatic and non-enzymatic effects beyond Alzheimer's disease
Sandra Lehnert et al.
CHANNELS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain
Kapil Gadkar et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System
Kathryn M. Munro et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
Claudia Cicognola et al.
MOLECULAR NEURODEGENERATION (2016)
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
Martina Pigoni et al.
MOLECULAR NEURODEGENERATION (2016)
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease
Riqiang Yan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease
Deepak Kumar Vijaya Kumar et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
BACE1 Physiolocical Functions May Limit Its Use as Therapeutic Tarcet for Alzneimer's Disease
Soraia Barao et al.
TRENDS IN NEUROSCIENCES (2016)
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
Andrea M. Zuhl et al.
NATURE COMMUNICATIONS (2016)
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Miriam Ries et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Proteomic Substrate Identification for Membrane Proteases in the Brain
Stephan A. Mueller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs
Riqiang Yan
TRANSLATIONAL NEURODEGENERATION (2016)
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2015)
Potential role of antimicrobial peptides in the early onset of Alzheimer's disease
Mick M. Welling et al.
ALZHEIMERS & DEMENTIA (2015)
Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
Severin Filser et al.
BIOLOGICAL PSYCHIATRY (2015)
Prospects of -Secretase Inhibitors for the Treatment of Alzheimer's Disease
Arun K. Ghosh et al.
CHEMMEDCHEM (2015)
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease
Robert J. Baranello et al.
CURRENT ALZHEIMER RESEARCH (2015)
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
Yasuhiko Kizuka et al.
EMBO MOLECULAR MEDICINE (2015)
β-Secretase BACE1 Regulates Hippocampal and Reconstituted M-Currents in a β-Subunit-Like Fashion
Sabine Hessler et al.
JOURNAL OF NEUROSCIENCE (2015)
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease
Sergio T. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells
Asuka Kokawa et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Computational Methods in the Discovery and Design of BACE-1 Inhibitors
P. Kacker et al.
CURRENT MEDICINAL CHEMISTRY (2015)
CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
Bruce Albala et al.
Alzheimers & Dementia (2014)
A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease
Eric Karran et al.
ANNALS OF NEUROLOGY (2014)
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease
Arun K. Ghosh et al.
CHEMICAL SOCIETY REVIEWS (2014)
Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
Janice A. Maloney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
Robert Vassar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Riqiang Yan et al.
LANCET NEUROLOGY (2014)
Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease
Mikhil N. Bamne et al.
NEUROBIOLOGY OF AGING (2014)
The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease
Xiaofang Cheng et al.
NEUROBIOLOGY OF AGING (2014)
Inhibition of Amyloid Precursor Protein Processing Leads to Downregulation of Apoptotic Genes in Alzheimer's Disease Animal Models
Inna Rabinovich-Nikitin et al.
NEURODEGENERATIVE DISEASES (2014)
Sorting the Role of SORLA in Alzheimer's Disease
Virginie Buggia-Prevot et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Robert Vassar
ALZHEIMERS RESEARCH & THERAPY (2014)
Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies
Stefania Butini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
IL-1 receptor 2 (IL-1R2) and its role in immune regulation
Vanessa A. Peters et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
On the Interaction of β-Amyloid Peptides and α7-Nicotinic Acetylcholine Receptors in Alzheimer’s Disease
Murat Oz et al.
Current Alzheimer Research (2013)
Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
Andrew Stamford et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Allosteric inhibition of BACE1 by an exosite-binding antibody
Weiru Wang et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2013)
Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles
Cyril Cheret et al.
EMBO JOURNAL (2013)
Two phases of disulfide bond formation have differing requirements for oxygen
Marianne Koritzinsky et al.
JOURNAL OF CELL BIOLOGY (2013)
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease
Jing Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes
Frauke van Bebber et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
A Paired RNAi and RabGAP Overexpression Screen Identifies Rab11 as a Regulator of β-Amyloid Production
Vinod Udayar et al.
CELL REPORTS (2013)
BACE1 Regulates Hippocampal Astrogenesis via the Jagged1-Notch Pathway
Xiangyou Hu et al.
CELL REPORTS (2013)
Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing
Xingrong Liu et al.
DRUG METABOLISM AND DISPOSITION (2013)
The Upside of APP at Synapses
Hyang-Sook Hoe et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2012)
ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
Jun Cai et al.
EMBO MOLECULAR MEDICINE (2012)
β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
Brian Hitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus
Eugene L. Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Developing ß-secretase inhibitors for treatment of Alzheimer's disease
Arun K. Ghosh et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
Eric M. Reiman et al.
LANCET NEUROLOGY (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease
Luxiang Cao et al.
SCIENTIFIC REPORTS (2012)
Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer's disease and beyond
Bastian Dislich et al.
FRONTIERS IN PHYSIOLOGY (2012)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Inhibition of β-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1
Lujia Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cleavage of Neuregulin-1 by BACE1 or ADAM10 Protein Produces Differential Effects on Myelination
Xiaoyang Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
Tharinda W. Rajapaksha et al.
MOLECULAR NEURODEGENERATION (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
Jasvinder K. Atwal et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The Role of Seizure-Related SEZ6 as a Susceptibility Gene in Febrile Seizures
John C. Mulley et al.
NEUROLOGY RESEARCH INTERNATIONAL (2011)
Amyloid-beta as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Ubiquitin Regulates GGA3-mediated Degradation of BACE1
Eugene L. Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease A NOVEL TOOL FOR THERAPY AND DIAGNOSIS
Oliver Wirths et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Xiangyou Hu et al.
JOURNAL OF NEUROSCIENCE (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization
Brian D. Hitt et al.
MOLECULAR NEURODEGENERATION (2010)
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Stephanie J. Soscia et al.
PLOS ONE (2010)
Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
Hyunbum Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Crystal structure of human pepsin and its complex with pepstatin
Masao Fujinaga et al.
PROTEIN SCIENCE (2010)
Predicting memapsin 2 (β-secretase) hydrolytic activity
Xiaoman Li et al.
PROTEIN SCIENCE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
The basics of preclinical drug development for neurodegenerative disease indications
Karen L. Steinmetz et al.
BMC NEUROLOGY (2009)
Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts
Kulandaivelu S. Vetrivel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Two Endoplasmic Reticulum (ER)/ER Golgi Intermediate Compartment-based Lysine Acetyltransferases Post-translationally Regulate BACE1 Levels
Mi Hee Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
Michela Guglielmotto et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain
Hoau-Yan Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
K. A. Bates et al.
MOLECULAR PSYCHIATRY (2009)
Non-proteolytic effect of β-site APP-cleaving enzyme 1 (BACE1) on sodium channel function
Tobias Huth et al.
NEUROBIOLOGY OF DISEASE (2009)
Multifunctional aspartic peptidase prosegments
Yasumi Horimoto et al.
NEW BIOTECHNOLOGY (2009)
Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics
Matthew L. Hemming et al.
PLOS ONE (2009)
Design of potent aspartic protease inhibitors to treat various diseases
Jeffrey-Tri Nguyen et al.
ARCHIV DER PHARMAZIE (2008)
Requirements for a lead compound to become a clinical candidate
Franz F. Hefti
BMC NEUROSCIENCE (2008)
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
Xiangyou Hu et al.
FASEB JOURNAL (2008)
p3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers
Fabienne Dulin et al.
FEBS LETTERS (2008)
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Solomon S. Shaftel et al.
JOURNAL OF NEUROINFLAMMATION (2008)
BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus
Hui Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons
Anja Schneider et al.
JOURNAL OF NEUROSCIENCE (2008)
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production
Hideaki Shimizu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
Stephan Schilling et al.
NATURE MEDICINE (2008)
BACE1 gene deletion:: Impact on behavioral function in a model of Alzheimer's disease
Dione Kobayashi et al.
NEUROBIOLOGY OF AGING (2008)
β-secretase as a therapeutic target for Alzheimer's disease
Arun K. Ghosh et al.
NEUROTHERAPEUTICS (2008)
Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice
A. V. Savonenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1
Claudio Costantini et al.
BIOCHEMICAL JOURNAL (2007)
Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization
Wan-Pin Chang et al.
FASEB JOURNAL (2007)
BACE1 regulates voltage-gated sodium channels and neuronal activity
Doo Yeon Kim et al.
NATURE CELL BIOLOGY (2007)
Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase
Peer-Hendrik Kuhn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
Fernanda G. De Felice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation
Xian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Xiulian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Control of peripheral nerve myelination by the β-secretase BACE1
Michael Willem et al.
SCIENCE (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Physiological roles for amyloid β peptides
Hugh A. Pearson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions
FM Laird et al.
JOURNAL OF NEUROSCIENCE (2005)
Lipids as modulators of proteolytic activity of BACE - Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro
L Kalvodova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression and activity of β-site amyloid precursor protein cleaving enzyme in Alzheimer's disease
JA Johnston et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
BACE is degraded via the lysosomal pathway
YH Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice
D Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neuregulin-1 type III determines the ensheathment fate of axons
C Taveggia et al.
NEURON (2005)
An alternative interpretation of the amyloid Aβ hypothesis with regard to the pathogenesis of Alzheimer's disease
VT Marchesi
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase
HK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease
C Lindberg et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Inhibition of amyloid precursor protein processing by β-secretase through site-directed antibodies
M Arbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate
CAF von Arnim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
GGA proteins mediate the recycling pathway of memapsin 2 (BACE)
XY He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications
JL Moreland et al.
BMC BIOINFORMATICS (2005)
BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
EB Lee et al.
JOURNAL OF CELL BIOLOGY (2005)
Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease
AK Ghosh et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Axonal neuregulin-1 regulates myelin sheath thickness
GV Michailov et al.
SCIENCE (2004)
β-amyloid directly inhibits human α4β2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells
J Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Insights into the phosphoregulation of β-secretase sorting signal by the VHS domain of GGA1
T Shiba et al.
TRAFFIC (2004)
Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy
CAF von Arnim et al.
JOURNAL OF CELL SCIENCE (2004)
In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors
WP Chang et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1
SF Lichtenthaler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biochemical and structural characterization of the interaction of memapsin 2 (β-secretase) cytosolic domain with the VHS domain of GGA proteins
XY He et al.
BIOCHEMISTRY (2003)
Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes
A Kinoshita et al.
JOURNAL OF CELL SCIENCE (2003)
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
R Ehehalt et al.
JOURNAL OF CELL BIOLOGY (2003)
Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha 7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells
XYD Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
BACE1 (beta-secretase) transgenic neurochernical deficits ind knockout mice: identification of and behavioral changes
SM Harrison et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Aβ 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis
WL Wei et al.
BRAIN (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Memapsin 2 (β-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2:: implications on the endocytosis mechanism of memapsin 2
XY He et al.
FEBS LETTERS (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total Aβ
L Pastorino et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase
S Kitazume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structure-based design:: Potent inhibitors of human brain memapsin 2 (β-secretase)
AK Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Subsite specificity of memapsin 2 (β-secretase):: Implications for inhibitor design
RT Turner et al.
BIOCHEMISTRY (2001)
Post-translational processing of β-secretase (β-amyloid-converting enzyme) and its ectodomain shedding -: The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-β production
S Benjannet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Proteolytic activation of recombinant pro-memapsin 2 (pro-β-secretase) studied with new fluorogenic substrates (vol 39, pg 12450, 2000)
J Ermolieff et al.
BIOCHEMISTRY (2000)
A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's β-secretase
BD Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme -: The Alzheimer's disease β-secretase
JT Huse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Maturation and pro-peptide cleavage of β-secretase
A Capell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
β-amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity -: Implications for Alzheimer's disease pathology
HY Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase
A Solans et al.
CYTOGENETICS AND CELL GENETICS (2000)
分享论文
